Invivyd announced the appointment of Jeremy Gowler as chief operating and commercial officer, effective December 16 and the promotion of Pete Schmidt, M.D. to chief medical officer, effective immediately. In his new role Mr. Gowler will oversee operations and commercial activities for the company. Dr. Schmidt will be responsible for overseeing all medical, clinical development and regulatory activities at Invivyd. Dr. Ellie Hershberger, Invivyd’s chief development officer, is departing from the Company, but is anticipated to provide consulting services for development activities.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on IVVD:
- Invivyd Appoints Jeremy Gowler as Chief Operating and Commercial Officer, Promotes Pete Schmidt, M.D., to Chief Medical Officer
- Invivyd Announces Partnership With Population Health Partners to Accelerate Clinical Development in Infectious Diseases Including COVID-19
- Invivyd reports Q3 EPS (42c), consensus (49c)
- Invivyd Reports Third Quarter 2022 Financial Results and Business Highlights
- Invivyd to Host Conference Call on November 10 to Discuss Third Quarter 2022 Financial Results and Recent Business Highlights